Bio

Quentin has more than 9 years of experience in Private Equity within the healthcare space with 10 Growth/Buyout investments performed in that domain since 2011. His career started within Mérieux Equity Partners in 2011 as Analyst. Previously, he interned at Rothschild Martin Maurel as a financial analyst. Quentin is now Investment Manager and actively works on the sourcing, evaluation, and monitoring of Mérieux Equity Partners’ investments. He is based in Paris and is currently board member of Biobest, GTP Bioways and CTRS and observer of Addmedica and Serb. Quentin has a Master degree in Finance and Management from the Reims Business School and a European Business Management License from the University of Coventry (England).